NimBio

NimBio

NimBio

NimBio develops non-invasive diagnostic tools for early disease detection using advanced biosensing.

2019Active5San Francisco, United States
Rate

About

NimBio offers a proactive care solution for Inflammatory Bowel Disease (IBD) patients through its Inflammometer™ platform, which uses passive biosensing for real-time inflammation monitoring and early flare detection. This platform aims to provide effortless, remote, and personalized care for patients, while enhancing care delivery for hospitals and physicians, optimizing treatment for pharma, and reducing hospitalizations for payers. NimBio's solution focuses on identifying flare causes and offering therapeutic recommendations to prevent complications and optimize IBD management.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to NimBio?

People comparing tools land here. Get listed beside these.

Copy NimBio's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
nimbio.ai
Headquarters
San Francisco, United States
Founded
2019
Founder
Tal Atarot
Employees
5
Business model
B2B

Funding rounds

Funding rounds raised by NimBio
DateRoundAmountLead investors
7 Dec 2022Pre-SeedUndisclosedeHealth Ventures

Tech stack

Detected on nimbio.ai, last scanned 22 Nov 2026.

Email provider
Google Workspace

Benchmarking

See how your site ranks against 16,849 startups

NimBio sits in the 12th percentile for Domain Rating. Check where yours lands, free.

NimBio has a Domain Rating of 7, the 12th percentile of 16,849 startups we track.

Scores

Measured, not editorial

7

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Bottom 25%

Check yours
28

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Bottom 25%

Scan yours

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

NimBio scores 28. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when NimBio changes

Used NimBio? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Who owns NimBio?

NimBio is privately held, owned by its founders and investors. Investors on record include eHealth Ventures. Exact stakes are not public.

Are there companies like NimBio?

Yes. We list 7 companies like NimBio, including Kinsa, X-trodes and BrainQ.

How many employees does NimBio have?

NimBio has approximately 5 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for NimBio:

Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch NimBio and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini